Research Article
Sustained Clinical Efficacy and Mucosal Healing of Thiopurine Maintenance Treatment in Ulcerative Colitis: A Real-Life Study
Table 1
Demographic and clinical characteristics of patients.
| | Patient |
| Gender (%) | | Female | 104 (54.1) | Male | 88 (45.9) | Age, years | | Median (range) | 36 (16–69) | Disease duration, years | | Median (range) | 3.3 (0–31) | Disease extension (%) | | Extensive colitis | 117 (60) | Left-sided colitis | 75 (40) | Mayo endoscopic subscore (%) | | Mayo 1 | 16 (9) | Mayo 2 | 91 (52) | Mayo 3 | 68 (39) | Smoking habit (%) | | Yes | 23 (12) | No/former smoker | 169 (88) | Indication for starting thiopurines (%) | | Steroid dependency | 111 (58) | Maintenance after a severe attack | 36 (19) | Frequent relapses | 45 (23) | Cotreatment with mesalazine (%) | 175 (91.1) | Duration of thiopurine therapy, months | | Median (range) | 36 (1–210) |
|
|